Provider
According to a study published in JAMA, audio-only visits made up one in five primary care visits and two in five behavioral health visits among patients at federally qualified health centers in August 2022.
        
        
          Multiple sclerosis patients using Walgreens' neurology-specialty pharmacies will have access to Cariloop's Care Coaches.
        
        
          
          HIMSS23
          
      
                    
            
  Tina Manoharan, VP of the Data and AI Center of Excellence at Philips, will speak at HIMSS23 about how to build AI insights for health systems by using real-world data.
        
        
          
          HIMSS23
          
      
                    
            
  Dr. Tufia Haddad, Becky Kottschade and Rebecca Heft discuss their HIMSS23 presentation detailing the Mayo Clinic's approach to implementing decentralized clinical trials.
        
        
          The company's Auto B-line Counter product uses AI to help providers assess abnormal lung conditions.
        
        
          Peter Micca, audit and assurance partner and national health tech leader at Deloitte, discusses the health tech funding and economic environment.
        
        
          
          HIMSS23
          
      
                    
            
  Matthew Fisher, general counsel at Carium, previews his upcoming HIMSS23 panel on how the Supreme Court's decision in Dobbs v. Jackson Women's Health Organization caused conflicting rules and regulations nationwide and affected healthcare data and access.
        
        
          
          HIMSS23
          
      
                    
            
  Dr. Cecil Lynch, chief medical information officer at Accenture, discusses his upcoming HIMSS23 lecture on genomics' potential impact on patient care and the importance of examining genetic information and its relationship to comorbidities.
        
        
          The prescription digital therapeutics company is pursuing a sale of the business or its assets.
        
        
          The medtech company will use the funds to speed up product innovation and expand its reach globally.
        
        
           
 
 
 
 
 
 
 
